ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,680,000 | -64.5% | 480,000 | 0.0% | 0.88% | -56.6% |
| Q1 2021 | $4,733,000 | -9.0% | 480,000 | 0.0% | 2.02% | -17.6% |
| Q4 2020 | $5,203,000 | +5.2% | 480,000 | 0.0% | 2.44% | -3.6% |
| Q3 2020 | $4,944,000 | -50.7% | 480,000 | 0.0% | 2.54% | -52.4% |
| Q2 2020 | $10,022,000 | +113.7% | 480,000 | 0.0% | 5.33% | +79.2% |
| Q1 2020 | $4,690,000 | -15.2% | 480,000 | 0.0% | 2.97% | +19.7% |
| Q4 2019 | $5,530,000 | +111.4% | 480,000 | 0.0% | 2.48% | +107.0% |
| Q3 2019 | $2,616,000 | -54.2% | 480,000 | 0.0% | 1.20% | -54.3% |
| Q2 2019 | $5,707,000 | +126.9% | 480,000 | 0.0% | 2.62% | +141.8% |
| Q1 2019 | $2,515,000 | +66.3% | 480,000 | 0.0% | 1.08% | +52.2% |
| Q4 2018 | $1,512,000 | -47.9% | 480,000 | 0.0% | 0.71% | -34.3% |
| Q3 2018 | $2,904,000 | +14.2% | 480,000 | 0.0% | 1.08% | +2.7% |
| Q2 2018 | $2,544,000 | -8.6% | 480,000 | 0.0% | 1.06% | +32.0% |
| Q1 2018 | $2,784,000 | +65.7% | 480,000 | 0.0% | 0.80% | +62.6% |
| Q4 2017 | $1,680,000 | – | 480,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |